January 11th, 2021 (Lure, France) - Vetoquinol announced today the acquisition of the Australian rights to Drontal® and Profender® product families from Elanco Animal Health.
Vetoquinol has acquired the Drontal® and Profender® product families, the intellectual property, registrations and other rights from Elanco Animal Health for the Australian market. The Drontal® and Profender® families of products are spot-on and tablet de-wormer products for cats and dogs.
In August 2020, Vetoquinol acquired the Profender® and Drontal® product families in the EU and the UK in relation to Elanco’s 2020 acquisition of Bayer AG’s animal health business. Vetoquinol’s acquisition of these product families for Australia has been approved by the Australian Competition and Consumer Commission (ACCC).
Matthieu Frechin, CEO of Vetoquinol, said "We are very pleased to acquire the Drontal® and Profender® product lines for the Australian market, one of our strategic countries. The acquisition of these strong brands for the Australian market confirms our ambition to become a major global player in the parasiticide segment. Adding these Essentials to our product portfolio in Australia will significantly boost our business in this strategic country.”
Latest news of vetoquinol
Vetoquinol welcomes the Positive Opinion from the European Committee for Medicinal Products for Veterinary Use (CVMP) recommending parasiticide Felpreva® for cats13 Sep 2021We are pleased to announce that the Committee for Medicinal Products for Veterinary Use (CVMP) has adopted a positive opinion recommending the...
29 Jul 2021STRONG PERFORMANCE ACROSS THE BOARD First half sales: €255m (up 33.5% at constant exchange rates) Essentials sales: €143m (up 45.2% at constant...